BioCentury
ARTICLE | Company News

Cholestech sales and marketing update

January 29, 1996 8:00 AM UTC

CTEC's L.D.X system will be used in a two-year 900-patient pharmacy-based cholesterol management project funded by Merck & Co. and administered by the American Pharmaceutical Association Foundation. The project's goal is to demonstrate pharmacists' ability to influence patient outcomes with drug therapy and behavior modification.

L.D.X uses a small quantity of blood collected from a finger stick to give a cholesterol profile, which will be used by pharmacists to communicate individualized cardiac risk probabilities to patients. ...